SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 1, 2001 (Date of earliest event reported) ALLERGY RESEARCH GROUP, INC. (Exact Name of Registrant as Specified in its Charter) Florida 0-27227 13-3940486 (State or Other (Commission (IRS Employer Jurisdiction of File Number) Identification Incorporation) Number) 30806 Santana Street, Hayward, California 94544 (Address of Principal Offices, including zip code) (800) 545-9960 (Registrant's telephone number, including area code) Item 5. Other Events Change of Name Effective March 1, 2001, Registrant changed its name from "Scottsdale Scientific, Inc." to "Allergy Research Group, Inc." pursuant to the vote of its shareholders held at its annual shareholders' meeting held December 18, 2000. As a result of the name change, the trading symbol for Registrant's common, currently being traded on the Pink Sheets, was changed from "STDS" to "ALRG" effective March 8, 2001, and the common stock was assigned a new CUSIP number. Item 7. Exhibits 99.1 Press Release, dated March 7, 2001. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALLERGY RESEARCH GROUP, INC. Dated: March 7, 2001 By: /s/ Stephen Levine ------------------------ Name: Stephen Levine Title: Chief Executive Officer